GlassScriptPhysician profile
Daniel Robert Nardi
NPI 1255971883
$3,159.99
in general payments reported to CMS, 2019-2025
39 companies · $984 in 2025
The $984 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $572 · 2022: $651 · 2023: $513 · 2024: $440 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,773 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,773.02 |
| Education | $164.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $478.77 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $405.86 | 2022-2025 | Airsupra, Breztri, Tezspire |
| Lilly USA, LLC | $283.85 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Abbvie INC. | $170.78 | 2021-2023 | |
| Glaxosmithkline, LLC. | $159.55 | 2021-2025 | Nucala, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $159.45 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Sanofi-Aventis U.S. LLC | $147.51 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $125.40 | 2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.06 | 2021-2024 | Jardiance |
| Genzyme Corporation | $98.98 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $88.54 | 2025 | Opsumit, Uptravi |
| Avion Pharmaceuticals | $77.50 | 2021-2022 | |
| Exact Sciences Corporation | $71.94 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $57.06 | 2023-2025 | Zoryve, Livalo |
| Verona Pharma, INC. | $54.25 | 2025 | Ohtuvayre |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.